Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 008
1301
mi
from
Cedarhurst, NY
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 008
1301
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 047
1286
mi
from
New York, NY
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 047
1286
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 058
1286
mi
from
New York City, NY
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 058
1286
mi
from
New York City, NY
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative site 098
732
mi
from
Cincinnati, OH
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative site 098
732
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 056
154
mi
from
Oklahoma City, OK
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 056
154
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site
1385
mi
from
Portland, OR
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site
1385
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 054
1207
mi
from
Allentown, PA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 054
1207
mi
from
Allentown, PA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site #008
965
mi
from
Bridgeville, PA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site #008
965
mi
from
Bridgeville, PA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site
479
mi
from
Memphis, TN
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site
479
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site
566
mi
from
Houston, TX
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site
566
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site
340
mi
from
Dallas, TX
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site
1402
mi
from
Bellevue, WA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site
1402
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site #027
1410
mi
from
Seattle, WA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site #027
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 069
1202
mi
from
Spokane, WA
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 069
1202
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 007
572
mi
from
Middleton, WI
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 007
572
mi
from
Middleton, WI
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/15/2013
Forest Investigative Site 056
636
mi
from
Milwaukee, WI
Safety and Efficacy of Vilazodone in Major Depressive Disorder
A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/15/2013
Forest Investigative Site 056
636
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
365
mi
from
Little Rock, AR
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
365
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1162
mi
from
Garden Grove, CA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1162
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1140
mi
from
National City, CA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1140
mi
from
National City, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1331
mi
from
Oakland, CA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1132
mi
from
Bradenton, FL
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1132
mi
from
Bradenton, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1320
mi
from
South Miami, FL
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1320
mi
from
South Miami, FL
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
mi
from
Marlton, NJ
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1289
mi
from
Brooklyn, NY
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1289
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
963
mi
from
New York, NY
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
963
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
743
mi
from
Dayton, OH
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
743
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1385
mi
from
Portland, OR
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1385
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
511
mi
from
Austin, TX
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
511
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
342
mi
from
Dallas, TX
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
342
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
566
mi
from
Houston, TX
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
566
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
1410
mi
from
Seattle, WA
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
Placebo-Controlled Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  3/8/2013
University of Utah
777
mi
from
Salt Lake City, UT
Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
Placebo-Controlled Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 3/8/2013
University of Utah
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD)
Efficacy and Safety of Cranial Electrical Stimulation (CES) for the Treatment of Major Depressive Disorder (MDD): A Pilot Study
Status: Enrolling
Updated:  4/22/2013
The Depression Clinical and Research Program, Massachusetts General Hospital
1444
mi
from
Boston, MA
Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD)
Efficacy and Safety of Cranial Electrical Stimulation (CES) for the Treatment of Major Depressive Disorder (MDD): A Pilot Study
Status: Enrolling
Updated: 4/22/2013
The Depression Clinical and Research Program, Massachusetts General Hospital
1444
mi
from
Boston, MA
Click here to add this to my saved trials
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
Status: Enrolling
Updated:  4/26/2013
New York State Psychiatric Institute
1290
mi
from
New York, NY
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
Status: Enrolling
Updated: 4/26/2013
New York State Psychiatric Institute
1290
mi
from
New York, NY
Click here to add this to my saved trials
Dopamine Neurotransmission in Major Depression
Dopamine Neurotransmission in Major Depression
Status: Enrolling
Updated:  5/2/2013
McLean Hospital
1438
mi
from
Belmont, MA
Dopamine Neurotransmission in Major Depression
Dopamine Neurotransmission in Major Depression
Status: Enrolling
Updated: 5/2/2013
McLean Hospital
1438
mi
from
Belmont, MA
Click here to add this to my saved trials
Dopamine Neurotransmission in Major Depression
Dopamine Neurotransmission in Major Depression
Status: Enrolling
Updated:  5/2/2013
Massachusetts General Hospital
1443
mi
from
Boston, MA
Dopamine Neurotransmission in Major Depression
Dopamine Neurotransmission in Major Depression
Status: Enrolling
Updated: 5/2/2013
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment Resistant Depression
Status: Enrolling
Updated:  5/16/2013
University of California, San Francisco
1339
mi
from
San Francisco, CA
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment Resistant Depression
Status: Enrolling
Updated: 5/16/2013
University of California, San Francisco
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site
683
mi
from
Birmingham, AL
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 295
mi
from
Sherman Oaks, CA
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 295
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 122
mi
from
Temecula, CA
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 122
mi
from
Temecula, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 606
mi
from
Jacksonville Beach, FL
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 606
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 127
mi
from
Lauderhill, FL
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 127
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site
1117
mi
from
Tampa, FL
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 096
801
mi
from
Atlanta, GA
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 096
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 195
mi
from
Park Ridge, IL
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 195
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 47
643
mi
from
Indianapolis, IN
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 47
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated:  5/23/2013
Teva Investigational Site 600
mi
from
Lafayette, IN
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Status: Enrolling
Updated: 5/23/2013
Teva Investigational Site 600
mi
from
Lafayette, IN
Click here to add this to my saved trials